Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Aug 27, 2021; 13(8): 859-870
Published online Aug 27, 2021. doi: 10.4240/wjgs.v13.i8.859
Published online Aug 27, 2021. doi: 10.4240/wjgs.v13.i8.859
Table 3 Gallbladder disease postoperative course and complications
| Gallbladder disease | |||||
| March–June 2019 | March–June 2020 | P value | |||
| 152 | 161 | ||||
| Length of stay for surgically managed patients (d), median (IQR) | 3 | (2–4) | 2 | (1–3) | 0.3 |
| Discharged on antibiotics, n (%) | 21 | 14% | 29 | 18% | 0.39 |
| Inpatient complications, n (%) | 10 | 16% | 11 | 13% | 0.62 |
| Sepsis | 0 | 0% | 4 | 5% | |
| Transaminitis | 1 | 2% | 1 | 1% | |
| Death | 0 | 0% | 1 | 1% | > 0.99 |
| Representation within 30 d, n (%) | 16 | 11% | 20 | 12% | 0.71 |
| Postoperative intra-abdominal abscess | 0 | 0% | 1 | 1% | |
| Cholecystitis | 3 | 2% | 4 | 2% | |
| Cholelithiasis/Choledocholithiasis | 1 | 1% | 5 | 3% | |
- Citation: Farber ON, Gomez GI, Titan AL, Fisher AT, Puntasecca CJ, Arana VT, Kempinsky A, Wise CE, Bessoff KE, Hawn MT, Korndorffer JR Jr, Forrester JD, Esquivel MM. Impact of COVID-19 on presentation, management, and outcomes of acute care surgery for gallbladder disease and acute appendicitis. World J Gastrointest Surg 2021; 13(8): 859-870
- URL: https://www.wjgnet.com/1948-9366/full/v13/i8/859.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i8.859